<div class="data-content">
  <div class="mxb-6 plr-1 ptb-0-2 head-content large"><b>Argatroban:</b></div>

  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Adult starting dose:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">0.2 μg/kg/min</div>

  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Pediatric starting dose:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">n/a</div>

  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Target range:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">aPTT 1.5–3× compared to baseline</div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">Lower targets in VV ECMO possible: aPTT 45–55 s (ratio 1.35–1.65)</div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">Hemoclot target: 0.4–0.6 µg/mL</div>

  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Hepatic impairment dose adjustment:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">YES—decrease starting dose (0.1 μg/kg/min)</div>

</div>